NCT05349370
Lactate Kinetics in Septic Shock
Lactate Kinetics in Patients Treated for Septic Shock
Karolinska University Hospital·ClinicalTrials.gov·otherNot yet recruiting
View on ClinicalTrials.gov →Study focus
- Disease/Condition
- Sepsis,Septic Shock
- Drug/Device/Intervention
- Isotopically labeled lactate
- Study type
- Interventional
- Intervention type
- other
Sponsor & location
- Primary sponsor
- Karolinska University Hospital
Timeline & enrollment
- Phase
- N/A
- Start date
- May 02, 2022
- End date
- Dec 31, 2024
- Enrollment
- 60 participants
Primary outcome
Whole body rate of appearance of lactate
Summary
Lactate kinetics will be studied in hospitalized septic patients using a bolus injection of
 stable isotopically labeled lactate.
ICD-10 classifications
Septic shockOther sepsisOther specified sepsisSepsis, unspecifiedSepsis due to other specified staphylococcus
Data source
- Registry
- ClinicalTrials.gov
- Trial ID
- NCT05349370
- Type
- Non-Device Trial
About this record
Access comprehensive clinical trial information for NCT05349370 through Pure Global AI's free database. This phase not specified trial is sponsored by Karolinska University Hospital and is currently Not yet recruiting. The study focuses on Sepsis,Septic Shock. Target enrollment is 60 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.